Khan Najat — SEC Form 4 filings
SEC reporting owner CIK 2020969. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-08-05 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 235,296 shares, $1,008,706 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 124,403 shares @ $4.41 ($548,592) in RECURSION PHARMACEUTICALS, INC., filed 2025-12-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | CEO and President, Director | 14 | — | 5 legs · 235,296 sh · $1,008,706 | 17 |
Form 4 filings — Khan Najat
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 22,408 @ $3.52 | EDGAR |
| 2026-08-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 80,498 @ $3.16 | EDGAR |
| 2026-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 23,588 @ $3.58 | EDGAR |
| 2026-05-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 62,701 @ $3.04 | EDGAR |
| 2026-03-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 28,298 @ $3.35 | EDGAR |
| 2026-02-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 14,280 @ $3.49 | EDGAR |
| 2026-02-10 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,673,546 @ $0 · Grant/award (A): 30,346 @ $0 · Tax withholding (F): 10,364 @ $3.98 | EDGAR |
| 2025-12-29 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 124,403 @ $4.41 | EDGAR |
| 2025-11-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 17,584 @ $4.14 | EDGAR |
| 2025-11-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 84,925 @ $0 · Grant/award (A): 169,851 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 3,789 @ $5.64 · Sale (S): 36,599 @ $5.52 | EDGAR |
| 2025-05-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 3,796 @ $4.25 | EDGAR |
| 2025-02-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 210,113 @ $0 · Grant/award (A): 8,049 @ $0 · Tax withholding (F): 2,753 @ $7.25 · Grant/award (A): 420,226 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 496,972 @ $0 · Grant/award (A): 993,944 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2020969 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →